Prevalence of Hepatitis C Virus among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model? DOI Open Access
Giulia Morsica,

Massimo Locatelli,

Gema Hernández

et al.

Published: Dec. 18, 2023

Free-of-charge HCV screening in some key populations and 1969–1989 birth cohorts have been funded Italy as the first step to diagnosing individuals unaware of their infection. The aim this study is use available in-hospital routine data understand inpatients a region North Italy. A retrospective search patients tested for HCV-antibody (HCV-Ab) from January 2017 end December 2022, was conducted according age categories (older than 76 years, group 1947-1968; group1969-1989 two other with younger 33 years) using TriNetX network. Of 42,805 tested, 1,297 (3.03%) resulted HCV-Ab positive. proportion decreased 2022 (from 2.03% 0.36%) years). higher prevalence older years (5.3%) while, lowest cohort (2000-2022, 0.16%). found positive, only 198 (15.3%) were presence RNA. Although 1969-1989 had lower seroprevalence (1.5%), they represented most affected 44.4% RNA positivity. including 1947-1989 could be valuable option respect general population. Since high not during hospitalization, reflex testing promptly ascertaining an active infection facilitate linkage care stop burden HCV.

Language: Английский

Prevalence of Hepatitis C Virus among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model? DOI Open Access
Giulia Morsica,

Massimo Locatelli,

Gema Hernández

et al.

Published: Dec. 18, 2023

Free-of-charge HCV screening in some key populations and 1969–1989 birth cohorts have been funded Italy as the first step to diagnosing individuals unaware of their infection. The aim this study is use available in-hospital routine data understand inpatients a region North Italy. A retrospective search patients tested for HCV-antibody (HCV-Ab) from January 2017 end December 2022, was conducted according age categories (older than 76 years, group 1947-1968; group1969-1989 two other with younger 33 years) using TriNetX network. Of 42,805 tested, 1,297 (3.03%) resulted HCV-Ab positive. proportion decreased 2022 (from 2.03% 0.36%) years). higher prevalence older years (5.3%) while, lowest cohort (2000-2022, 0.16%). found positive, only 198 (15.3%) were presence RNA. Although 1969-1989 had lower seroprevalence (1.5%), they represented most affected 44.4% RNA positivity. including 1947-1989 could be valuable option respect general population. Since high not during hospitalization, reflex testing promptly ascertaining an active infection facilitate linkage care stop burden HCV.

Language: Английский

Citations

1